APGE Stock Summary and Trading Ideas (Apogee Therapeutics | NASDAQ:APGE)

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

What symbol and exchange does Apogee Therapeutics shares trade?

Apogee Therapeutics trades on the NASDAQ stock market under the symbol APGE.

What is Apogee Therapeutics stock price doing today?

As of September 3, 2026, APGE stock price was flat at $135.07 with million shares trading.

What is Apogee Therapeutics's Beta?

APGE has a beta of -0.94, meaning it tends to be less sensitive to market movements. APGE has a correlation of 0.04 to the broad based SPY ETF.

How much is Apogee Therapeutics worth?

APGE has a market cap of $10.21 billion. This is considered a Large Cap stock.

How much money does Apogee Therapeutics make?

Last quarter Apogee Therapeutics reported $0 in Revenue and -$1.14 earnings per share. This fell short of revenue expectation by $-10 million and missed earnings estimates by -$.15.

What is the highest and lowest price Apogee Therapeutics traded in the last 3 year period?

In the last 3 years, APGE traded as high as $135.09 and as low as $14.19.

What are the top ETFs holding Apogee Therapeutics?

The top ETF exchange traded funds that APGE belongs to (by Net Assets): VTI, XBI, IWM, VB, VXF.

Is Apogee Therapeutics (APGE) a good investment?

APGE has outperformed the market in the last year with a return of +254.0%, while the SPY ETF gained +21.3%. In the last 3 month period, APGE beat the market returning +60.4%, while SPY returned +2.8%. However, in the most recent 2 weeks APGE has underperformed the stock market by returning +0.2%, while SPY returned +1.4%.

What are the support and resistance levels for Apogee Therapeutics (APGE)?

APGE support price is $134.96 and resistance is $135.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that APGE shares will trade within this expected range on the day.